SecBot SecBot
SECBOTREPLAY Home › Report › CHRN

CHRN · ChronoScale filed a DEFA14A supplement to its proxy statement removing…

ChronoScale Holdings Corp · DEFA14A filed Oct 16, 2026 at 17:00 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Oct 16, 2026 at 17:00 ET

ChronoScale filed a DEFA14A supplement to its proxy statement removing Scott G. Davis as a director nominee following his resignation in connection with the sale of subsidiary Ekso Bionics. The filing also discloses $709,500 in cash severance to Davis and $243,750 to Jason Jones, both tied to the Ekso disposition. The annual meeting on November 6, 2026, will proceed with seven director nominees instead of eight.

  • Scott G. Davis resigned from the board effective October 3, 2026, and is removed as a nominee for the 2026 annual meeting.
  • The board now has seven nominees: Wes Cummins, Ying Cenly Chen, Richard Nottenburg, Ella Benson, Douglas Miller, William M. Clancy, and Andrew Schaap.
  • Davis received 51,626 fully vested RSUs and a $709,500 cash release payment in connection with the Ekso sale.
  • Jason Jones was terminated as COO of Ekso and receives $243,750 cash severance plus up to nine months of COBRA premiums.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access